Benjamin McGraw

Benjamin F.
McGraw is currently Chairman & Chief Executive Officer at TheraVida, Inc. since 2014, Chairman & Chief Executive Officer at Auration Biotech, Inc. since 2014, Executive Chairman at Trefoil Therapeutics, Inc. since 2017, Chairman at Evommune, Inc. since 2020, Executive Chairman at Perfuse Therapeutics, Inc., and Venture Partner at Sanderling Management CO LLC.
Former roles include Chairman, President, CEO, CFO & CAO at Valentis, Inc. from 1994 to 2007, Executive Chairman at TRF Pharma, Inc., Chairman at Vaneltix Pharma, Inc. from 1994 to 2009, Director at ISTA Pharmaceuticals, Inc. from 2000 to 2002, Independent Director at Aerie Pharmaceuticals, Inc. in 2022, Vice President-Corporate Development at Allergan, Inc., Vice President-Development at Marion Merrell Dow, Inc. and Marion Laboratories from 1978 to 1989, Fund Manager & Equity Analyst at Carerra Capital Management, Inc., and Managing Member at Long Shadows Asset Management LLC from 2006 to 2014.
Education includes undergraduate and doctorate degrees from The University of Tennessee Health Science Center.